Eris Lifesciences Limited — Call Transcript 2023

May 12, 2023

==> picture [594 x 125] intentionally omitted <==

Date: 12[th] May 2023

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (“SEBI (LODR) Regulations, 2015”)

Dear Sir/Madam,

This is further to our letter dated 10[th] May 2023 intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended 31 March, 2023.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Wednesday, 17[th] May, 2023 at 05:00 p.m., IST. The details of the said call are attached herewith and also available on Company’s website.

Thanking you.

For Eris Lifesciences Limited

==> picture [234 x 96] intentionally omitted <==

----- Start of picture text -----

Digitally signed by MILIND TALEGAONKAR
DN: c=IN, postalCode=380055, st=GUJARAT,
MILIND street=E42 SHRI SADAN SHAHWADI VASNAAHMEDABADOPP SWAMINARAYAN2BEHIND
GB SHAH COLLEGE 380055, l=AHMEDABAD,
o=Personal, title=6609,
serialNumber=a508a80d3a9231304a5bf4e4182bcd
TALEGAON 5ae3ec1d08a10919025e2d5daa95b04426, pseudonym=660920220924180430743,
2.5.4.20=57785628ba3ced9959cf93cf3cf172cf4a41a
51eb72e155a16f1b8fb6276b3d4,
email=MILIND.TALEGAONKAR@ERISLIFESCIENCES.C
KAR OM, cn=MILIND TALEGAONKAR
Date: 2023.05.12 16:20:00 +05'30'
_______
Milind Talegaonkar
Company Secretary and Compliance Officer
Membership No.: A26493
----- End of picture text -----

Encl.: a/a

==> picture [592 x 72] intentionally omitted <==

==> picture [101 x 58] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Earnings Conference Call

To discuss the financial and operational performance for

Q4 & FY 23

Day/Date: Wednesday, 17[th] May, 2023

Time: 5:00 PM, IST

Option 1: Express Join with Diamond Pass[ TM]

Pre-register with the below link and join without waiting for the operator:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9237679&linkSecurityString=300af1996f

Option 2: Join through below Dial-In Numbers

Universal Dial-in Numbers

+91 22 6280 1472 / +91 22 7115 8839

		International Toll Free	International Toll Free
Argentina	0080014243444	Germany	0080014243444	Singapore	8001012045
Australia	1800053698	HongKong	800964448	South Korea	00180014243444
Belgium	0080014243444	Italy	0080014243444	Sweden	0080014243444
Canada	01180014243444	Japan	00531161110	Thailand	00180014243444
China	4008428405	Netherlands	08000229808	UK	08081011573
France	0800914745	Poland	008001124248	USA	18667462133

We look forward to your participation RSVP: Kruti Raval: kruti@erislifesciences.com